Terns Pharmaceuticals receives FDA breakthrough designation for TERN-701

April 27, 2026 8:05 AM

Terns Pharmaceuticals Inc. (NASDAQ: TERN) announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to TERN-701 for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found